Search for Clinical Trial Results
Nerve Degeneration - 25 Studies Found
Status | Study |
Completed |
Study Name: Effects of Cocoa Flavanols on Human Cognitive Function Condition: Neural Degeneration Date: 2011-04-27 Interventions: Dietary Supplement: Cocoa Drink High Flavanol (495mg) Low Flavanol (23mg) Matched for macro and micro nu |
Completed |
Study Name: Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease Condition:
|
Completed |
Study Name: Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs Condition:
|
Recruiting |
Study Name: Effect of Fingolimod on Neurodegeneration Condition:
Date: 2015-10-12 Interventions: Drug: 0,5 mg Fingolimod Treatment will be 0.5 mg p.o fingolimod daily |
Recruiting |
Study Name: NBIAready: Online Collection of Natural History Patient-reported Outcome Measures Condition: Neurodegeneration With Brain Iron Accumulation (NBIA) Date: 2015-10-23 |
Active, not recruiting |
Study Name: Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) Condition:
Date: 2009-05-21 Interventions: Drug: Deferiprone 15 mg/Kg/twice for 1 year Other Na |
Completed |
Study Name: Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis Condition: Multiple Sclerosis Date: 2010-02-17 Interventions: Drug: Tysabri Infuse TYSABRI® 300 mg in 100 mL 0.9% Sodium Chloride Injection, USP over approximate |
Recruiting |
Study Name: Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach Condition: Mild Cognitive Impairment Date: 2015-03-24 Interventions:
|
Recruiting |
Study Name: Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential Condition: Multiple Sclerosis, Relapsing-Remitting Date: 2015-03-31 Interventions: Drug: Alemtuzumab |